Obstetrics & Gynecology Doctors in Kingston, PA Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Fereshteh Boozarjomehri, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 190 Welles St Ste 112-114, Kingston, PA 18704 Phone: 570-714-1099    Fax: 570-714-1116

Dr. Michael Miller, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 676 Wyoming Ave, Suite 104, Kingston, PA 18704 Phone: 570-287-1400

Dr. Bonita M Mancia, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 440 Pierce St, Kingston, PA 18704 Phone: 570-288-6521    Fax: 570-288-8284

Mark S Polin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 445 Wyoming Ave, Kingston, PA 18704 Phone: 570-714-2300

Michael Joseph Paglia, MD, PHD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 190 Welles St, Kingston, PA 18704 Phone: 570-714-1099    Fax: 570-714-1116

Dr. George C. Tsoutsoplides, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 534 Wyoming Avenue, Kingston, PA 18704 Phone: 570-287-5900    Fax: 570-287-6610

News Archive

18F-fluoride PET/MR imaging could diagnose cause of foot pain better than other methods

A single scan could diagnose the cause of foot pain better and with less radiation exposure to the patient than other methods, according to a study in the March 2015 issue of The Journal of Nuclear Medicine.

Researchers provide new insights into how calcium signals trigger wound healing

In a sharp and pointy world, wound healing is a critical and marvelous process. Despite a tremendous amount of scientific study, many outstanding mysteries still surround the way in which cells in living tissue respond to and repair physical damage.

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announces the enrolment and treatment of the first patient in its multicentre Phase I clinical trial of SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma. The trial will evaluate the safety and tolerability of SCIB1 in patients with late stage melanoma.

A 2% decline in U.S. birth rate including teenage births

According to Government statistics released this Tuesday, the birthrate in the United States has dropped by 2% from 2007 to 2008 with about 4.2 million babies born during this time. This drop also means that the fertility rate has gone below 2.1 children per woman. This statistic means that Americans are not giving birth to enough children to keep the population from declining.

Transcept Pharmaceuticals to discuss the Complete Response Letter for Intermezzo NDA

Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.

Read more Medical News

› Verified 7 days ago